Skip to main content
. 2019 Oct 29;2019:5930627. doi: 10.1155/2019/5930627

Table 1.

Basic information of included studies.

Study ID Participant Acute or preventive treatment Intervention Control Outcome measures Design Trials (participants) Risk of bias assessment tool
Linde et al. [14] Migraine patients NR Acupuncture ①②③ At least one clinical outcome related to headache RCT 26 (1151) Risk of bias approach for Cochrane reviews
Linde et al. [7] Episodic migraine patients Preventive treatment Acupuncture with or without manual or electrical stimulation ①②③ Headache frequency, response, and quality of life RCT 22 (4985) α
Chen et al. [15] Migraine patients NR Acupuncture RCT 18 (1730) β
Chen [16] Migraine patients NR Acupuncture Acupuncture not according to meridians;①②③ and other treatments RCT 18 (1672) α
Chu et al. [17] Migraine patients NR Acupuncture ②③ NR RCT 24 (2397) α
Cui et al. [18] Migraine patients NR Acupuncture with or without electrical stimulation ②③ and other treatments. RCT 15 (1288) α
Dai and Lin [19] Migraine patients NR Acupuncture NR NR RCT 2 (140) β
Gao et al. [20] NR NR Acupuncture RCT 12 (1744) β
Yang et al. [21] Migraine patients NR Acupuncture At least one clinical outcome related to headache RCT 10 (997) α
Zheng and Hai [22] Migraine patients NR Acupuncture NR NR RCT 33 (3593) α
Zhao [23] Menstrual migraine patients NR Acupuncture with or without other treatments ②③ and other treatments. ⒶⒷⒸ, pain index, pain time, symptom score, and biochemical indexes. RCT 18 (1268) α
Pu [24] Migraine patients Preventive treatment Acupuncture ⒶⒷⒸ, migraine days, migraine frequency, times of analgesics used, and follow-up rate. RCT 7 (1285) α
Pu et al. [25] Migraine patients Acute treatment Acupuncture RCT 5 (618) α
Song et al. [26] Migraine patients Preventive treatment Acupuncture with or without electrical stimulation or placebo ③ with or without placebo Ⓑ, pain days, and other outcome. RCT 18 (1470) α
Yang et al. [27] Migraine patients NR Acupuncture ⒷⒸ; pain index RCT 10 (893) α

NR: not reported in inclusion criteria; ①: no acupuncture; ②: sham acupuncture; ③: drug treatment; Ⓐ: visual analogue scale (VAS) pain score; Ⓑ: efficacy: Ⓒ: adverse events; α: Cochrane risk of bias assessment tool [28]; β: Jadad scale [29].